Dr. Zamora is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
OH State Univ Coll of Med
Columbus, OH 43085
Education & Training
- Detroit Medical Center/Wayne State UniversityResidency, Radiation Oncology, 2022
- OhioHealth/Riverside Methodist HospitalInternship, Transitional Year, 2017 - 2018
- Ohio State University College of MedicineClass of 2017
Certifications & Licensure
- MI State Medical License 2018 - 2025
- OH State Medical License 2017 - 2020
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 64 citationsTheoretical and Experimental Studies of the Spin Trapping of Inorganic Radicals by 5,5-Dimethyl-1-Pyrroline N-Oxide (DMPO). 3. Sulfur Dioxide, Sulfite and Sulfate Radi...Pedro L. Zamora, Frederick A. Villamena
The Journal of Physical Chemistry. A. 2012-07-05 - 6 citationsClinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma.C. Barney, Steve Walston, Pedro Zamora, E. Healy, Nicole Nolan
Oral Oncology. 2018-04-01 - 1 citationsTangential Volumetric Modulated Arc Therapy for Locally Advanced Breast Cancer.Pedro L Zamora, Geoffrey Baran, Christopher Nagle, Ahmad Hammoud, Michael Dominello
Practical Radiation Oncology. 2021-12-11
Journal Articles
- Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinomaChristian L. Barney, Steve Walston, Pedro Zamora, Erin H. Healy, Nicole Nolan, Virginia M. Diavolitsis, Anterpreet Neki, Robert Rupert, Panos Savvides, Amit Agrawal, M..., Oral Oncology, 4/2018
- Carboplatin Versus Cetuximab Chemoradiation in Cisplatin Ineligible Patients with Locally Advanced p16 Negative Head and Neck Squamous Cell CarcinomaC. Barney, E. Healy, P. Zamora, J. Aljabban, S.A. WalstonJr., V.M. Diavolitsis, D.M. Blakaj, J.L. Wobb, D.L. Mitchell, J.C. Grecula, A. Neki, R. Rupert, P. Savvides, A..., International Journal of Radiation Oncology*Biology*Physics, 10/2017
- OC-0331: Cetuximab versus Platinum-based Chemoradiation in Locally Advanced p16 Positive Oropharyngeal CancerC. Barney, S. Walston, P. Zamora, N. Nolan, V. Diavolitsis, D. Blakaj, J. Wobb, D. Mitchell, J. Grecula, P. Savvides, A. Bhatt, Radiotherapy & Oncology, 5/2017
Press Mentions
- Yes We Cannabis! Missouri-Made Medical Marijuana Moves MetroApril 20th, 2021
- On World AIDS Day, Learn About Pitt’s Work and ImpactDecember 1st, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: